News | March 07, 2023
Evonik partners with AMSilk to manufacture sustainable silk proteins
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
Receives regulatory approval for its molecule ‘Selumetinib’ in India
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
Dr. Adams brings more than two decades of experience leading the manufacturing of biologic and gene therapies at all stages of development.
This sBLA submission is supported by clinical, pre-clinical, and manufacturing data demonstrating the safety, tolerability, and immunogenicity of the bivalent vaccine.
Projected ~US$100 million cash balance of combined company expected to fund operations through mid-2025 and to clinical data over the next 12 to 24 months
Subscribe To Our Newsletter & Stay Updated
